Annual Total Liabilities:
$154.58M-$85.28M(-35.56%)Summary
- As of today, ABCL annual total liabilities is $154.58 million, with the most recent change of -$85.28 million (-35.56%) on December 31, 2024.
- During the last 3 years, ABCL annual total liabilities has fallen by -$138.26 million (-47.21%).
- ABCL annual total liabilities is now -49.75% below its all-time high of $307.63 million, reached on December 31, 2022.
Performance
ABCL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$227.45M+$63.42M(+38.66%)Summary
- As of today, ABCL quarterly total liabilities is $227.45 million, with the most recent change of +$63.42 million (+38.66%) on June 1, 2025.
- Over the past year, ABCL quarterly total liabilities has increased by +$50.13 million (+28.27%).
- ABCL quarterly total liabilities is now -40.89% below its all-time high of $384.78 million, reached on March 31, 2022.
Performance
ABCL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ABCL Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | -35.6% | +28.3% |
3Y3 Years | -47.2% | -40.3% |
5Y5 Years | +1067.8% | +253.6% |
ABCL Total Liabilities Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | -49.8% | at low | -33.6% | +47.1% |
5Y | 5-Year | -49.8% | +1067.8% | -40.9% | +328.0% |
All-Time | All-Time | -49.8% | +1464.1% | -40.9% | +1618.4% |
ABCL Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $227.45M(+38.7%) |
Mar 2025 | - | $164.03M(+6.1%) |
Dec 2024 | $154.58M(-35.6%) | $154.58M(-10.5%) |
Sep 2024 | - | $172.69M(-2.6%) |
Jun 2024 | - | $177.33M(-20.3%) |
Mar 2024 | - | $222.60M(-7.2%) |
Dec 2023 | $239.86M(-22.0%) | $239.86M(-27.2%) |
Sep 2023 | - | $329.42M(-3.8%) |
Jun 2023 | - | $342.34M(+18.3%) |
Mar 2023 | - | $289.42M(-5.9%) |
Dec 2022 | $307.63M | $307.63M(+1.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $302.24M(-20.7%) |
Jun 2022 | - | $380.93M(-1.0%) |
Mar 2022 | - | $384.78M(+31.4%) |
Dec 2021 | $292.84M(+67.3%) | $292.84M(+33.5%) |
Sep 2021 | - | $219.34M(+19.1%) |
Jun 2021 | - | $184.18M(+7.5%) |
Mar 2021 | - | $171.40M(-2.1%) |
Dec 2020 | $175.03M(+1222.4%) | $175.03M(+229.3%) |
Sep 2020 | - | $53.15M(-17.4%) |
Jun 2020 | - | $64.32M(+386.0%) |
Dec 2019 | $13.24M(+33.9%) | $13.24M |
Dec 2018 | $9.88M | - |
FAQ
- What is AbCellera Biologics Inc. annual total liabilities?
- What is the all-time high annual total liabilities for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual total liabilities year-on-year change?
- What is AbCellera Biologics Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly total liabilities year-on-year change?
What is AbCellera Biologics Inc. annual total liabilities?
The current annual total liabilities of ABCL is $154.58M
What is the all-time high annual total liabilities for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual total liabilities is $307.63M
What is AbCellera Biologics Inc. annual total liabilities year-on-year change?
Over the past year, ABCL annual total liabilities has changed by -$85.28M (-35.56%)
What is AbCellera Biologics Inc. quarterly total liabilities?
The current quarterly total liabilities of ABCL is $227.45M
What is the all-time high quarterly total liabilities for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly total liabilities is $384.78M
What is AbCellera Biologics Inc. quarterly total liabilities year-on-year change?
Over the past year, ABCL quarterly total liabilities has changed by +$50.13M (+28.27%)